Finally, we will discuss the possible role of other serine proteases active in the atria (mast-cell chymases and dipeptidyl-peptidase 4) and the possible efficacy of their selective inhibitors in modulating the risk of AF. The gene discussed is DPP4; the disease is atrial fibrillation.